401 related articles for article (PubMed ID: 18656225)
1. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment.
Radjenović J; Petrović M; Ventura F; Barceló D
Water Res; 2008 Aug; 42(14):3601-10. PubMed ID: 18656225
[TBL] [Abstract][Full Text] [Related]
2. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
Kimura K; Iwase T; Kita S; Watanabe Y
Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
[TBL] [Abstract][Full Text] [Related]
3. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
4. Rejection of pharmaceuticals by forward osmosis membranes.
Jin X; Shan J; Wang C; Wei J; Tang CY
J Hazard Mater; 2012 Aug; 227-228():55-61. PubMed ID: 22640821
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of RO/NF membranes at the removal of veterinary antibiotics.
Dolar D; Vuković A; Ašperger D; Košutić K
Water Sci Technol; 2012; 65(2):317-23. PubMed ID: 22233911
[TBL] [Abstract][Full Text] [Related]
7. Viability of a low-pressure nanofilter in treating recycled water for water reuse applications: a pilot-scale study.
Bellona C; Drewes JE
Water Res; 2007 Sep; 41(17):3948-58. PubMed ID: 17582458
[TBL] [Abstract][Full Text] [Related]
8. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments.
Boleda MA; Galceran MA; Ventura F
Environ Pollut; 2011 Jun; 159(6):1584-91. PubMed ID: 21459501
[TBL] [Abstract][Full Text] [Related]
9. Fouling of reverse osmosis and nanofiltration membranes by dairy industry effluents.
Turan M; Ates A; Inanc B
Water Sci Technol; 2002; 45(12):355-60. PubMed ID: 12201123
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis.
Beier S; Köster S; Veltmann K; Schröder H; Pinnekamp J
Water Sci Technol; 2010; 61(7):1691-8. PubMed ID: 20371926
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply.
Zuehlke S; Duennbier U; Heberer T
Chemosphere; 2007 Nov; 69(11):1673-80. PubMed ID: 17662339
[TBL] [Abstract][Full Text] [Related]
12. Removal of bisphenol A (BPA) from water by various nanofiltration (NF) and reverse osmosis (RO) membranes.
Yüksel S; Kabay N; Yüksel M
J Hazard Mater; 2013 Dec; 263 Pt 2():307-10. PubMed ID: 23731784
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide removal from water by nanofiltration and reverse osmosis membrane.
Wang L; Albasi C; Faucet-Marquis V; Pfohl-Leszkowicz A; Dorandeu C; Marion B; Causserand C
Water Res; 2009 Sep; 43(17):4115-22. PubMed ID: 19592068
[TBL] [Abstract][Full Text] [Related]
14. Removal of toxic ions (chromate, arsenate, and perchlorate) using reverse osmosis, nanofiltration, and ultrafiltration membranes.
Yoon J; Amy G; Chung J; Sohn J; Yoon Y
Chemosphere; 2009 Sep; 77(2):228-35. PubMed ID: 19679331
[TBL] [Abstract][Full Text] [Related]
15. Nutrient removal by NF and RO membranes in a decentralized sanitation system.
van Voorthuizen EM; Zwijnenburg A; Wessling M
Water Res; 2005 Sep; 39(15):3657-67. PubMed ID: 16054670
[TBL] [Abstract][Full Text] [Related]
16. Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden.
Flyborg L; Björlenius B; Persson KM
Water Sci Technol; 2010; 61(5):1113-20. PubMed ID: 20220232
[TBL] [Abstract][Full Text] [Related]
17. Fate of pharmaceuticals during indirect potable reuse.
Drewes JE; Heberer T; Reddersen K
Water Sci Technol; 2002; 46(3):73-80. PubMed ID: 12227606
[TBL] [Abstract][Full Text] [Related]
18. Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water.
Verliefde AR; Heijman SG; Cornelissen ER; Amy G; Van der Bruggen B; van Dijk JC
Water Res; 2007 Aug; 41(15):3227-40. PubMed ID: 17583761
[TBL] [Abstract][Full Text] [Related]
19. Determination and occurrence of organic micropollutants in reverse osmosis treatment for advanced water reuse.
Gomez V; Majamaa K; Pocurull E; Borrull F
Water Sci Technol; 2012; 66(1):61-71. PubMed ID: 22678201
[TBL] [Abstract][Full Text] [Related]
20. High performance RO membranes for desalination and wastewater reclamation and their operation results.
Henmi M; Fusaoka Y; Tomioka H; Kurihara M
Water Sci Technol; 2010; 62(9):2134-40. PubMed ID: 21045342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
